Pulsenmore to Report 2025 Earnings Amid U.S. Market Expansion Push
Event summary
- Pulsenmore Ltd. will release full-year 2025 earnings on March 30, 2026, at 8:30 a.m. EST.
- Executive leadership, including CEO Dr. Elazar Sonnenschein and CFO Eran Hirsh, will host the earnings call.
- The company is focusing on U.S. market expansion following its Nasdaq listing and FDA De Novo authorization.
- Pulsenmore's technology connects mothers and healthcare providers remotely via home-use ultrasound.
The big picture
Pulsenmore's earnings release comes at a critical juncture as it seeks to solidify its position in the U.S. maternal health market. The company's focus on telemedicine and remote prenatal care aligns with broader industry trends toward patient-centric healthcare solutions. With its Nasdaq listing and FDA authorization, Pulsenmore is well-positioned to capitalize on the growing demand for accessible prenatal care technologies.
What we're watching
- Market Penetration
- How Pulsenmore will sustain its clinician adoption expansion in the U.S. market.
- Regulatory Compliance
- Whether the company can maintain compliance in new and existing markets.
- Execution Risk
- The pace at which Pulsenmore can achieve key performance milestones in operational testing.
Related topics